These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21247123)

  • 1. 2-phenylsubstituted-3-hydroxyquinolin-4(1H)-one-carboxamides: Structure-cytotoxic activity relationship study.
    Soural M; Hlavác J; Funk P; Dzubák P; Hajdúch M
    ACS Comb Sci; 2011 Jan; 13(1):39-44. PubMed ID: 21247123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Aryl-4-hydroxyquinolin-2(1H)-one derivatives as type I fatty acid synthase inhibitors.
    Rivkin A; Kim YR; Goulet MT; Bays N; Hill AD; Kariv I; Krauss S; Ginanni N; Strack PR; Kohl NE; Chung CC; Varnerin JP; Goudreau PN; Chang A; Tota MR; Munoz B
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4620-3. PubMed ID: 16784844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, cytotoxic activity, DNA topoisomerase-II inhibition, molecular modeling and structure-activity relationship of 9-anilinothiazolo[5,4-b]quinoline derivatives.
    Loza-Mejía MA; Olvera-Vázquez S; Maldonado-Hernández K; Guadarrama-Salgado T; González-Sánchez I; Rodríguez-Hernández F; Solano JD; Rodríguez-Sotres R; Lira-Rocha A
    Bioorg Med Chem; 2009 May; 17(9):3266-77. PubMed ID: 19364657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
    Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitrypanosomal and antileishmanial activities of novel N-alkyl-(1-phenylsubstituted-beta-carboline)-3-carboxamides.
    Tonin LT; Panice MR; Nakamura CV; Rocha KJ; dos Santos AO; Ueda-Nakamura T; da Costa WF; Sarragiotto MH
    Biomed Pharmacother; 2010 Jul; 64(6):386-9. PubMed ID: 20382497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Study of the Structure-Diuretic Activity Relationship in a Series of New
    Ukrainets IV; Golik MY; Sidorenko LV; Korniyenko VI; Grinevich LA; Sim G; Kryvanych OV
    Sci Pharm; 2018 Aug; 86(3):. PubMed ID: 30158453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides.
    Raffa D; Maggio B; Cascioferro S; Raimondi MV; Schillaci D; Gallo G; Daidone G; Plescia S; Meneghetti F; Bombieri G; Di Cristina A; Pipitone RM; Grimaudo S; Tolomeo M
    Eur J Med Chem; 2009 Jan; 44(1):165-78. PubMed ID: 18485541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of new 1,8-naphthyridin-4(1H)-on-3-carboxamide and quinolin-4(1H)-on-3-carboxamide derivatives as CB2 selective agonists.
    Manera C; Benetti V; Castelli MP; Cavallini T; Lazzarotti S; Pibiri F; Saccomanni G; Tuccinardi T; Vannacci A; Martinelli A; Ferrarini PL
    J Med Chem; 2006 Oct; 49(20):5947-57. PubMed ID: 17004710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and cytotoxic activity of N-[(alkylamino)alkyl]carboxamide derivatives of 7-oxo-7H-benz[de]anthracene, 7-oxo-7H-naphtho[1,2,3-de]quinoline, and 7-oxo-7H-benzo[e]perimidine.
    Bu X; Chen J; Deady LW; Smith CL; Baguley BC; Greenhalgh D; Yang S; Denny WA
    Bioorg Med Chem; 2005 Jun; 13(11):3657-65. PubMed ID: 15862994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-(Benzo[d][1,3]dioxol-5-ylamino)-N-(4-fluorophenyl)thiophene-2-carboxamide overcomes cancer chemoresistance via inhibition of angiogenesis and P-glycoprotein efflux pump activity.
    Mudududdla R; Guru SK; Wani A; Sharma S; Joshi P; Vishwakarma RA; Kumar A; Bhushan S; Bharate SB
    Org Biomol Chem; 2015 Apr; 13(14):4296-309. PubMed ID: 25758415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Oxo-1,4-dihydro-quinoline-3-carboxamides as BACE-1 inhibitors: synthesis, biological evaluation and docking studies.
    Liu P; Niu Y; Wang C; Sun Q; Zhai Y; Yu J; Sun J; Xu F; Yan G; Huang W; Liang L; Xu P
    Eur J Med Chem; 2014 May; 79():413-21. PubMed ID: 24763262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
    Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
    Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and cytotoxic evaluation of 1-carboxamide and 1-amino side chain substituted β-carbolines.
    Ma C; Cao R; Shi B; Zhou X; Ma Q; Sun J; Guo L; Yi W; Chen Z; Song H
    Eur J Med Chem; 2010 Nov; 45(11):5513-9. PubMed ID: 20846759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 5-phenoxy-1,3-dimethyl-1H-pyrazole-4-carboxamides as potent agonists of TGR5 via sequential combinatorial libraries.
    Londregan AT; Piotrowski DW; Futatsugi K; Warmus JS; Boehm M; Carpino PA; Chin JE; Janssen AM; Roush NS; Buxton J; Hinchey T
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1407-11. PubMed ID: 23337601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
    Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
    J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitumor properties of N-[2-(dimethylamino)ethyl]carboxamide derivatives of fused tetracyclic quinolines and quinoxalines: a new class of putative topoisomerase inhibitors.
    Deady LW; Kaye AJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1997 Jun; 40(13):2040-6. PubMed ID: 9207945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 2-(4-biphenylyl)quinoline-4-carboxylate and carboxamide analogs. New human neurokinin-3 (hNK-3) receptor antagonists.
    Saudi MN; Rostom SA; Fahmy HT; El Ashmawy IM
    Arch Pharm (Weinheim); 2003 Jun; 336(3):165-74. PubMed ID: 12822182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, cytotoxic evaluation, and DNA binding of novel thiazolo[5,4-b]quinoline derivatives.
    Loza-Mejía MA; Maldonado-Hernández K; Rodríguez-Hernández F; Rodríguez-Sotres R; González-Sánchez I; Quintero A; Solano JD; Lira-Rocha A
    Bioorg Med Chem; 2008 Feb; 16(3):1142-9. PubMed ID: 18035542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of substituted 3-amino-N-phenyl-1H-indazole-1-carboxamides endowed with antiproliferative activity.
    Maggio B; Raimondi MV; Raffa D; Plescia F; Cascioferro S; Plescia S; Tolomeo M; Di Cristina A; Pipitone RM; Grimaudo S; Daidone G
    Eur J Med Chem; 2011 Jan; 46(1):168-74. PubMed ID: 21130540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.